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Abstract
Background: Respiratory syncytial virus (RSV) is a major cause of paediatric morbidity. Mathematical models can be used to
characterise annual RSV seasonal epidemics and are a valuable tool to assess the impact of future vaccines.
Objectives: Construct a mathematical model of seasonal epidemics of RSV and by fitting to a population-level RSV dataset,
obtain a better understanding of RSV transmission dynamics.
Methods: We obtained an extensive dataset of weekly RSV testing data in children aged less than 2 years, 2000–2005, for a
birth cohort of 245,249 children through linkage of laboratory and birth record datasets. We constructed a seasonally forced
compartmental age-structured Susceptible-Exposed-Infectious-Recovered-Susceptible (SEIRS) mathematical model to fit to
the seasonal curves of positive RSV detections using the Nelder-Mead method.
Results: From 15,830 specimens, 3,394 were positive for RSV. RSV detections exhibited a distinct biennial seasonal pattern
with alternating sized peaks in winter months. Our SEIRS model accurately mimicked the observed data with alternating
sized peaks using disease parameter values that remained constant across the 6 years of data. Variations in the duration of
immunity and recovery periods were explored. The best fit to the data minimising the residual sum of errors was a model
using estimates based on previous models in the literature for the infectious period and a slightly lower estimate for the
immunity period.
Conclusions: Our age-structured model based on routinely collected population laboratory data accurately captures the
observed seasonal epidemic curves. The compartmental SEIRS model, based on several assumptions, now provides a
validated base model. Ranges for the disease parameters in the model that could replicate the patterns in the data were
identified. Areas for future model developments include fitting climatic variables to the seasonal parameter, allowing
parameters to vary according to age and implementing a newborn vaccination program to predict the effect on RSV
incidence.
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Introduction
Respiratory syncytial virus (RSV) is the most common cause of
acute lower respiratory infections (ALRI) in children, especially
those aged less than two years. While RSV is not a notifiable
disease, the health and economic burden for young children
surpasses that of influenza in Australia, with an estimated
incidence ranging from 435–869/1000 infant population [1]. In
the United Kingdom RSV mortality rates in those aged less than
15 years have been shown to be on par with those of influenza [2].
RSV follows a distinct seasonality in most geographical areas with
peaks during winter months associated with cooler temperatures
and increased rainfall, [3–6] however RSV incidence can be
highly variable within countries and between regions within a
country depending on the level of seasonal forcing [7].
Mathematical models have been used in epidemiology to
characterise annual epidemics of respiratory infections and
measure the likely impact of intervention programs [8,9]. Models
can also determine the optimum timing of interventions and the
proportion of the population that need to be vaccinated in order to
reach the herd immunity threshold. There is currently no licenced
vaccine for RSV, but immunoprophylaxis with RSV-specific
monoclonal antibodies is effective in reducing RSV-related severe
disease [10]. Furthermore, an attenuated intranasal RSV/parain-
fluenza virus type 3 vaccine (MEDI-534) and a live attenuated
intranasal RSV vaccine (MEDI-559) have recently undergone
Phase 1 clinical trials in infants and young children [11,12].
Mathematical models are likely to be useful in assessing the impact
of such vaccines. However, to improve the accuracy of these
models, real population data are needed to fit the model
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parameters. Unlike notifiable diseases where positive detections
are reported nationally, RSV models rely on hospitalisations or
routinely collected laboratory data. To date, variations of simple
compartmental models for RSV have been constructed using
hospitalisation data from The Gambia, Singapore, Florida (USA)
and Finland [13] and Spain [14]. A further model has since been
developed using RSV testing data from a major children’s hospital
in Utah (USA) [15]. These models have shown that they can
reliably mimic the distinctive seasonal characteristics of RSV.
However, due to the differences in climate between these regions,
which result in different levels of seasonal forcing, RSV models
need to be developed and fitted to specific geographical areas.
We have access to total population-based linked data including
state-wide routinely collected laboratory data through the Western
Australian Data Linkage System (WADLS). Demographic, clinical
and laboratory data are linked following a best practice protocol
[16] in which personal identifiers are separated from health and
laboratory data and linked by a separate linkage team to produce a
project-specific child identifier key. De-identified data for each of
the datasets are then given to the approved research team for
analysis. In this study, we establish a compartmental model of
RSV transmission based on positive detections of RSV in
metropolitan Western Australian children, obtained through
population-based data linkage. Secondly, we explore variations
in the model fit with changes in the disease parameters of the
latency and infectious periods, and the reduction in the
susceptibility and infectiousness for older children and adults due
to reinfection and ageing.
Methods
Population and Setting
Western Australia covers approximately 2.5 million square
kilometres and has a population of 2.2 million [17]. The Western
Australian Department of Health classifies residential postcodes
into three major geographical regions: metropolitan (the capital
city, Perth, and its surrounds), rural (South West and North
Eastern areas outside of the metropolitan region) and remote (the
far East and far North Western Australia). The state crosses several
climatic zones with a temperate climate in the metropolitan and
southern regions and a tropical climate in the northern regions.
Approximately three-quarters of Western Australia’s population
reside in the metropolitan area. There is one dedicated tertiary
level paediatric teaching hospital, Princess Margaret Hospital for
Children (PMH) located in the state capital, Perth. At PMH, it is
standard practice to collect nasopharyngeal aspirates (NPA) for
respiratory virus detection on all children admitted to hospital with
ALRI [18]. A recommendation for respiratory pathogen testing is
in place at other smaller metropolitan and non-metropolitan
hospitals across Western Australia.
Population-based data
Previously we have extracted data from WADLS on 245, 249
singleton live births (7.1% of which are Aboriginal) in Western
Australia between 1996 and 2005 from the Midwives’ Notification
System, Birth and Death Register and the Hospital Morbidity
Database System. Details of data cleaning are provided elsewhere
[19,20]. In brief, our linked dataset contains information on birth
details, demographics and hospitalisation episodes for ALRI
between 1996 and 2005.
We have also extracted data from the PathWest Laboratory
Database concerning routine detections of respiratory viruses and
bacteria. PathWest Laboratory Medicine Western Australia (Path-
West) is the government-funded public laboratory service and
consists of all public pathology laboratories in Western Australia
and carries out a full range of diagnostic testing for infectious
diseases. Details of the component datasets within the PathWest
Laboratory Database are given elsewhere [21]. Laboratory data
were available from 2000 to 2005 for all children in the birth
cohort for ages 0–9 years. Respiratory samples received at
PathWest for viral testing are routinely investigated for RSV,
influenza viruses A and B, adenoviruses and parainfluenza virus
types 1–3. RSV was detected by either immunofluorescent antigen
detection, polymerase chain reaction (PCR) and/or viral culture.
Testing methods for RSV did not change between 2000 and 2005.
We used the residential postcode of the mother at the time of
her child’s birth as recorded on the Midwives’ Notification System
to classify laboratory detections to either the metropolitan, rural
and remote regions of Western Australia. To establish a model of
metropolitan RSV transmission in a temperate climate, we
restricted our data to RSV testing and positive detections in
children born in metropolitan areas. Ethical approval for this study
was granted by Princess Margaret Hospital for Children Ethics
Committee and the Department of Health Western Australia
Human Research Ethics Committee. Access to the population-
based data was approved by the Western Australian Data Linkage
Branch.
Model structure
We adapted the RSV compartmental transmission models used
by others [13,15,22] and constructed a Susceptible (S) – Exposed
(E) – Infectious (I) – Recovered (R) – Susceptible (S) model with
two age classes. S1, E1, I1 and R1 represented those individuals
aged less than 2 years and S2, E2, I2, and R2 represented those
individuals aged 2 years and over. Our SEIRS model was defined
by a series of differential equations:
dS1
dt
~m{bS1(I1zaI2){g1S1znR1
dE1
dt
~bS1 I1zaI2ð Þ{g1E1{sE1
dI1
dt
~sE1{g1I1{cI1
dR1
dt
~cI1{g1R1{nR1
dS2
dt
~g1S1{dbS2 I1zaI2ð Þ{g2S2znR2
dE2
dt
~g1E1zdbS2 I1zaI2ð Þ{g2E2{sE2
dI2
dt
~g1I1zsE2{g2I2{cI2
dR2
dt
~g1R1zcI2{g2R2{nR2
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where: m is the birth rate, b is the disease transmission rate, g1 is
the ageing rate from (SEIR)1 to (SEIR)2, g2 is the ageing rate of
leaving (SEIR)2 which is related to birth/death rate, 1/s is the
average latency period, 1/c is the average infectious period and 1/
n is the average duration of immunity. The scaling parameters a
and d represent the reductions in infectivity and susceptibility
respectively for the older age group compared to those aged less
than 2 years. Each model class represents the proportion of the
total population. A schematic representation of the model is shown
in Figure 1.
Parameters
The parameters were based either on real data from our
previous population-based data linkage studies, estimates from the
literature or were estimated during the model fitting process. Data
were aggregated at the weekly level so the time period of interest is
a week and all rates are quoted as per week for consistency.
Birth rate (m) and ageing rates (g1 and g2). Age class 1
represented those aged less than 2 years and age class 2
represented those aged 2 years or more. Therefore, the weekly
ageing rate was assumed to be 1/(2*52) for moving from (SEIR)1
to (SEIR)2. We assumed an overall stable population with a life
expectancy of 80 years and that deaths in those aged less than 2
years are insignificant to the older age group following Keeling
and Rohani [22]. Therefore the rate of entering the model, or the
birth/death rate, was assumed to be equal to the ageing rate for
leaving (SEIR)2 and was calculated as 1/(78*52).
Latency period (1/s). The latency period is defined as the
time between being infected and becoming infectious. Based on
previous literature [13], this was initially assumed to be an average
of 4 days (0.57 of a week). Values between 2 and 6 days were later
tested to determine the effect on the model fit.
Infectious period (1/c). The infectious period estimates the
time an individual remains infectious. Previous RSV models have
assumed this to be 10 days [13–15]. This estimate has been based
on a previous analysis of 23 infants where the average duration of
shedding of RSV was 6.7 days with a range from 1–21 days [23].
In order to be consistent with the literature, our initial model
assumed an average infectious period of 10 days (1.4 weeks).
Values between 7 and 12 days for this parameter were later tested
to determine the effect on the model fit.
Duration of immunity (1/n). The duration of immunity is
defined as the time between entering the recovery state to
becoming susceptible again for a subsequent RSV infection. In
previous literature [13] the duration of immunity has been
estimated to be 200 days (25.6 weeks). In a more recent RSV
model, the duration of immunity that produced the best fit to the
data was a yearly rate of 1.59 which approximately translates to
230 days (32.9 weeks) [14]. Due to the seasonal nature of RSV
epidemics the duration of immunity is difficult to measure from
observational data as the risk of reinfection depends on the time of
year of the first infection. An infection late in an epidemic season
has a lower risk of reinfection that season than an earlier infection
and is more likely to be reinfected in the following season. This
effect greatly biases the calculation of the duration of immunity
and probably leads to an overestimate. Due to the great
uncertainty in this parameter and its impact on the outcome in
the model we elected to make the duration of immunity a variable
to be fitted rather than estimated from the literature.
Transmission parameter (b). To account for the distinct
seasonality of RSV, the disease transmission parameter was
calculated as follows:
b~b0 1zb1 cos
2pt
52
zw
  
This is based on harmonic analysis that we have previously
shown to accurately model RSV seasonality in metropolitan
Western Australia [3]. This seasonality function allowing for
varying amplitude over an annual cycle with a horizontal shift is
common in modelling seasonal outbreaks and has been used in
previous RSV transmission models [13,14,22]. The component
parameters b0, b1 and Q (phase shift) were estimated through the
model fitting process with t representing time in weeks. Here b0 is
the average transmission rate and b1 is the degree of seasonality
which is defined over the range [0,1] with higher values more
appropriate for regions with stronger seasonal drivers.
Scaled susceptibility (d). To account for less reported
infections in those aged 2 years or more, we included a scaling
parameter to reduce the susceptibility of the older age class being
infected by both infectious age classes. Based on reinfection studies
[24,25] initially the scaling parameter was set to 0.65 and later a
range from 0.5 to 0.8 was considered.
Scaled infectiousness (a). To account for reduced trans-
mission in those aged 2 years or more, we included a scaling
parameter to reduce the transmission from the infected population
in the older age class, to the susceptible population in both age
classes. The literature on the level of transmission from older
children and adults to younger children is scarce, thus as a starting
point in the model we set the scaled infectiousness to be the same
Figure 1. Schematic representation of RSV SEIRS model with two age groups. (SEIRS)1 represents those aged less than 2 years and (SEIRS)2
represents those aged 2 years or more.
doi:10.1371/journal.pone.0100422.g001
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as the scaled susceptibility, at 0.65 with a range from 0.5 to 0.8
considered.
Model fitting
The SEIRS model was developed in Cran R statistical package
[26], using the deSolve function to numerically solve the differential
equations and verified in MATLAB. The model was used to fit the
components of the seasonal transmission parameter, b0, b1 and Q,
and the inverse of the immunity period n. The model was fitted to
data regarding positive RSV detections in children aged less than 2
years between 2000 and 2005 in metropolitan Western Australia.
Since the model is a population wide model based on proportions
in each class and the data are for reported RSV cases from
population-based linked data, the model results were scaled to
represent this proportion of the total community cases. This
scaling was done by ensuring the total number of cases over the 6
years of the study and the model agreed. After using a set of initial
conditions for b0, b1, Q and n, we used the Nelder-Mead method
in Cran R with the neldermead package [27] to fit the model to our
actual RSV data. The weekly cumulative number of cases in the
first age class (children aged less than 2 years) from the model and
the real data was used in the model fitting process. The fit statistic
that was minimised during the model fitting process was defined
as:
F~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃXn
i~1
datai{SEIRSið Þ2
s
where datai and SEIRSi are the weekly number of cases aged less
than 2 years in the data and SEIRS model outcome and i is the
index for all weeks from the beginning of 2000 until the end of
2005. In contrast to Leecaster and colleagues [15] the fit statistic is
not scaled by the model value as this gives a poorer fit due to the
long periods over the summer months with very small case
numbers.
In addition to fitting the components of the transmission
parameter and the immunity parameter, we explored the variation
in the fitted value of these four parameters and the model fit
statistic by varying the duration of the latency period (2 to 6 days),
the recovery period (7 to 12 days), and the scaled infectiousness
and susceptibility parameters (0.5 to 0.8). The variations used were
based on a literature search and the epidemiology of RSV
detections and hospitalisations using our Western Australian data.
Results
RSV detections
There were 15,830 specimens collected in metropolitan children
aged less than 2 years between 2000 and 2005 that were tested for
RSV with 21% (n= 3394) being positive for RSV by direct
immunofluorescence, viral culture or PCR. Of the positive RSV
detections, 89.7% were identified from specimens collected from
hospitalised children, 9.4% were identified from specimens
collected from non-hospital patients, that is patients attending
emergency departments or hospital associated out-patient clinics,
and the remaining 0.9% were collected in children from private
laboratories associated with general practices. There were 4813
specimens in those aged 2–8 years that were tested and from those
11% (n= 534) were positive for RSV. Specimens tested and found
positive for RSV followed a clear seasonal pattern with peaks in
the winter months of June to August and very few cases during the
summer months of December to February (Figure 2). There was
also a distinct biennial seasonal pattern in both testing and positive
detections with alternating peaks. The average maximum number
of weekly detections in the higher peaks for years 2000, 2002 and
2004 was 73 compared with an average of 45 detections per week
for years 2001, 2003 and 2005. The proportion of specimens
tested that were positive for RSV ranged from 0% in off season
months to 74% in the peak periods.
SEIRS model
The SEIRS model was fitted to the 6 years of RSV positive
identifications. The transmission parameter values that minimised
the fit statistic using the Nelder-Mead method were b0 = 1.99,
b1 = 0.65, Q=2.43 and n=0.044 (translating to an immunity
period of about 23.5 weeks), resulting in a fit statistic of F = 89.575.
This best fit of the model to the data displayed alternating peak
sizes that accurately mimicked the observed data (Figure 3). In
contrast to the models of Leecaster and colleagues [15] the
parameter values used here are constant across the entire dataset
and do not vary by epidemic year. That is, there is a natural period
2 oscillation in the model with these parameter values giving the
alternating peaks observed in the data. Using different parameter
values for different years was not required to achieve the biennial
cycle. The biennial cycle was found to exist over a range of
parameter values and was not restricted to narrow parameter
choices. It should be noted that there are other regions of the
parameter space that had a poorer fit to the data that did not
exhibit this period 2 oscillation but instead had peaks of equal size
as has been observed in some other models [13,14].
Parameter variation
We explored differences in the fit statistic and transmission
parameter values through the variation of duration of the latency
and infectious periods, and the scaling parameters for reduced
susceptibility and infectiousness in the older age class. A summary
of the results is given in Table 1. We did not investigate the
variation in the parameter w because this simply represents the
horizontal fitting of the model to the dataset and does not change
the dynamics of the system overall.
Based on the available literature, our initial estimate of the
latency period was 4 days. To allow for variation around this
value, we tested values within the range of 2 days (weekly rate of
1/0.28) and 6 days (weekly rate of 1/0.86) All values within this
range produced a good model fit (F = 90.03 to F= 92.32; Table 1),
with the best fit agreeing with our initial estimate of 4 days.
Similar to other RSV models, our model initially assumed the
infectious period to be 10 days. This original estimate was based
on a study reporting the mean duration of shedding of RSV to be
6.7 days with the range of 1–21 days [23]. An additional study
found the shedding duration to be between 3.4 and 7.4 days but
considerably longer (9 days and potentially longer) for children
aged less than 2 years [28]. While we do not have available viral
shedding data, we explored hospital length of stay as a proxy for
the infectious period. This assumes that infectiousness is linked to
symptom presentation which may not be true. In addition, patients
may be discharged from hospital whilst still showing symptoms
that are not serious enough to warrant continued hospitalisation. It
is expected that hospital stay would be an underestimation of
infectious period. From linking the RSV laboratory data to
hospitalisation data, we identified 2,424 hospitalisations in
children aged less than 2 years in metropolitan Western Australia.
The median length of hospital stay was 3 days with the range of 0–
6 days. To allow for additional time before and after the hospital
stay, where a child may still be infectious, we explored models with
infectious periods of 7 days (weekly rate of 1/1) to 12 days (weekly
rate of 1/1.7). Despite the epidemiology of RSV infections in
Modelling Respiratory Syncytial Virus in Children
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Western Australia suggesting the optimal estimate for the
infectious period in the vicinity of 5–12 days, only periods in the
range of 8–11 days were successful in producing a model with the
biennial seasonal pattern; outside this range the model gave an
annual pattern which does not concord with the data.
Very few studies have been undertaken to ascertain to what
level RSV is transmitted from adults to children, with RSV in
Figure 2. Weekly number of specimens tested and found positive for RSV in metropolitan Western Australian children aged less
than 2 years from January 2000 to December 2005.
doi:10.1371/journal.pone.0100422.g002
Figure 3. Observed RSV identifications in those aged less than 2 years and the fitted SEIRS model. The parameters used in the model
are a= 0.65; d= 0.65; c= 1/1.4; and s= 1/0.57, producing a fit statistic of F = 89.5751.
doi:10.1371/journal.pone.0100422.g003
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adults most often presenting as the ‘‘common cold’’ [24]. One
study by Henderson et al (1979) found that the attack rate for first
RSV infection was 98%, 75% for second infections and 65% for
third infections [25]. As such, values between 0.5 and 0.8 were
tested for the scaling parameters a and d. Suitable model fits, close
to the optimal fit, were found for all tests in this range, with the
best fits for values between 0.6 and 0.7.
For the parameter ranges tested, the fitted duration of immunity
had little variation with typical values around 160 days
(n=0.0438) and a range from 148 to 164 days. As expected, the
most sensitive fit parameter was the average transmission
parameter b0. Reducing either the susceptibility or infectiousness
for the older age class required an increase in the transmission rate
for the model to fit the data. Increasing the infectious period
reduced the required level of transmission. Varying the latency
period did not have a significant impact on the transmission
parameter. The fitted value of the seasonality parameter, b1, was
consistent across the sensitivity analysis with a value typically
around 0.65 and a range from 0.59 to 0.68. The only other model
that has been fitted to biennial pattern RSV data assumed an
overly large seasonal forcing parameter of b1 = 1 and required
other parameters to vary season by season to obtain a good fit to
the data [15].
The best fitting transmission estimates and the corresponding fit
statistic for the different combinations of the duration of immunity
and recovery period are shown in Table 1. The fit statistic for
realistic parameter choices ranged from F=89.575 (the best fit) to
92.324. A number of parameter choices produced seasonal
epidemics curves of alternating peak sizes, consistent with the
RSV data. However, the model that minimised the residual sum of
errors assumed a latency period of 4 days and infectious period of
10 days, in keeping with earlier estimates in the literature.
Discussion
RSV is the most commonly detected pathogen in children with
ALRI and both RSV testing and positive detections in Western
Australia exhibit distinct seasonality with alternating peaks in
winter months. Using positive RSV detections obtained through
population-based data linkage, we have constructed a simple
mathematical model to mimic these seasonal patterns of detections
in the metropolitan population of Western Australia. Our age-
structured model accurately captures the biennial seasonal
epidemic curves that were observed in children aged less than 2
years between 2000 and 2005. The compartmental SEIRS model,
based on several assumptions, now provides a base model on
which to expand and increase complexity.
All models are based on assumptions of epidemiological
parameters of the disease in question. There is a paucity in the
literature of the characteristics of RSV infection including
duration of shedding and infectiousness. Previous models have
used the infectious period of 10 days based on a study of 23 infants
[23]. In another Kenyan community study of 193 children, the
mean duration of shedding was 4.5 days and varied between
severity of infection and recent history of infection [29]. While we
investigated models with infectious periods ranging from 7 to 12
days, we could only replicate the biennial seasonal peaks of RSV
with infectious periods between 8 and 11 days; outside this range a
suitable fit could not be found with only annual patterns produced
by the model.
Our initial estimate for the duration of immunity was 200 days
(,6.6 months), based on previous RSV models in the literature
[13]. We investigated this estimate using data regarding RSV
reinfections. From our linked laboratory data, there were 4,920
RSV positive identifications between 2000 and 2005 throughout
Western Australia in those aged less than 2 years. Of these, 92.6%
were single infections and 363 (7.4%) were reinfections (6.3% were
second time infections, 0.7% third time infections and 0.2% fourth
time infections). Excluding those reinfections with positive RSV
identifications from specimens collected less than 14 days apart
(most likely to be indicative of the same infection), there were 99
reinfections where the time between positive RSV identification
was .14 days. Of these 99 reinfections, 80 were identified in
children from metropolitan Western Australia. The mean time
between subsequent RSV infections from reinfections in metro-
politan children was 250 days (8.21 months) and the range was
15–592 days. However, the duration of immunity that the
produced the best fit for the model was 160 days. It is possible
that immunity wanes several months before the onset of a
subsequent RSV season, but that there are not enough infected
individuals in the population at that time for the infection to gain
momentum and hence our estimate of the immunity period from
the data is an overestimate.
We have identified several improvements that can be made to
the model which will become the focus of future work. First, we
will improve the age structure of the model to allow the
Table 1. Sensitivity analysis of the fit statistic and fitted transmission parameters for varying duration of immunity and infectious
period.
Test conducted Parameter variation Fitting parameters Fit statistic (F)
Parameter Value tested b0 b1 n
Parameters for best fit: a=0.65; d=0.65; c= 1/1.4; s= 1/0.57 - - 1.9896 0.6495 0.0438 89.5751
Reduction in infectiousness for adults a 0.5 2.5639 0.6775 0.0454 90.3653
a 0.8 1.6300 0.6262 0.0436 89.6733
Reduction in susceptibility for adults d 0.5 2.5534 0.6279 0.0445 90.1470
d 0.8 1.6488 0.6667 0.0468 90.2240
Variation to latency period 1/s 1/0.28 1.9113 0.5879 0.0474 90.0338
1/s 1/0.86 2.1255 0.6618 0.0457 92.3239
Variation to infectious period 1/c 1/1.14 2.3617 0.6478 0.0464 91.6664
1/c 1/1.57 1.8289 0.6599 0.0428 90.2565
The assumed values of the parameters are a= 0.65; d= 0.65; c= 1/1.4; and s= 1/0.57 unless otherwise varied, as indicated in the table.
doi:10.1371/journal.pone.0100422.t001
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transmission parameters to vary between the different age groups
as opposed to our current model where we assume the same
transmission rate for each age group with a fixed scaling
parameter. The incidence of RSV is greater in infants aged less
than 12 months than those in the second year of life, as we have
previously shown with hospitalisation rates for bronchiolitis for
which RSV is mostly associated [19]. Therefore a natural next step
is to further refine the age classes into those aged less than 12
months, 12–23 months and 2 years and over. This will result in a
higher number of parameters to fit to the data and therefore will
increase the complexity of the model. The advantage is that age-
specific interventions, such as vaccination, are easily incorporated
in the modelling framework.
Second, we will introduce non-metropolitan data on RSV
detections and investigate the changes in the parameters. Parts of
rural and remote Western Australia experience tropical climate
and therefore, are very likely to experience a different seasonal
pattern in terms of peak height and duration. Our total
population-based data allows us to investigate seasonality based
on geographical location. To achieve this accurately, we will
investigate whether the transmission parameters can be modelled
as functions of climatic variables of each geographical region such
as average weekly temperatures, rainfall and humidity. A study in
Utah correlated climatic variables to hospitalisation data coded for
RSV and RSV-bronchiolitis and concluded that temperature and
wind speed were the best fitting climatic variables [30]. Due to the
differing geographical regions, the effect of corresponding climatic
variables on RSV detections may be different in Australia. Indeed,
other RSV transmissions with an annual pattern have had lower
estimates for the seasonal forcing parameter b1, depending on the
climatic region. In models from tropical regions, b1 has been
typically small (e.g. Gambia: 0.16–0.20; Florida: 0.10–0.13 and
Singapore: 0.14–0.20); whereas models from temperate climate
regions with more distinct seasonality have a larger b1 (e.g.
Finland: 0.16–0.39) [13].
Third, to measure the likely impact of future interventions, we
will model the introduction of a newborn vaccination program and
predict the effect on RSV incidence. Such analyses have been
previously attempted by modelling [14] and economic models
using Monte Carlo simulation methods [31]. However, until such
time as accurate vaccine efficacy estimates can be derived from
vaccine trial data, these models will continue to be based on
multiple assumptions. The benefit of this modelling approach is
that different scenarios around age of vaccination, efficacy and
waning period of the vaccine can be investigated to inform future
vaccination policy.
We also did not investigate RSV transmission by Aboriginality
or other risk groups for RSV. Our previous analysis of
metropolitan RSV identifications showed no difference in
seasonality of RSV in metropolitan Aboriginal and non-Aboriginal
children [3]. However, as we extend our model to include non-
metropolitan data, disaggregating according to Aboriginality will
be important due to the higher burden of illness in Aboriginal
children from rural and remote areas [32,33].
Conclusions
We have successfully developed a model to mimic the biennial
seasonal epidemic curves of RSV identifications in metropolitan
Western Australia. A strength of our model is the quality of data
that it is based on, gathered from individual-level linked total
population-based data sources. Not all RSV positive detections are
associated with hospitalisations so it is important to not limit data
sources to the severe end of the clinical spectrum. RSV continues
to be a major pathogen in children and until such time that
positive identifications of RSV become mandatory, future studies
will need to rely on routinely collected laboratory data.
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